The stock of Motif Bio PLC (LON:MTFB) is a huge mover today! The stock decreased 1.12% or GBX 0.25 on November 30, hitting GBX 22. About 979,482 shares traded hands or 2.29% up from the average. Motif Bio PLC (LON:MTFB) has declined 53.16% since April 29, 2016 and is downtrending. It has underperformed by 58.38% the S&P500.
The move comes after 9 months negative chart setup for the GBX 40.19M company. It was reported on Nov, 30 by Barchart.com. We have GBX 21.12 PT which if reached, will make LON:MTFB worth GBX 1.61M less.
Motif Bio PLC (LON:MTFB) Ratings Coverage
Out of 2 analysts covering Motif Bio Plc (LON:MTFB), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Motif Bio Plc has been the topic of 42 analyst reports since July 23, 2015 according to StockzIntelligence Inc. Northland Capital maintained Motif Bio PLC (LON:MTFB) rating on Monday, November 21. Northland Capital has “Buy” rating and GBX 114 price target. Northland Capital maintained Motif Bio PLC (LON:MTFB) on Tuesday, October 13 with “Buy” rating. The stock has “Speculative Buy” rating given by Beaufort Securities on Monday, November 21. The rating was maintained by Northland Capital on Thursday, September 3 with “Buy”. The firm earned “Buy” rating on Thursday, August 27 by Northland Capital. The stock has “Buy” rating given by Northland Capital on Wednesday, January 6. The stock of Motif Bio PLC (LON:MTFB) has “Speculative Buy” rating given on Friday, September 4 by Beaufort Securities. On Wednesday, December 16 the stock rating was maintained by Beaufort Securities with “Speculative Buy”. Beaufort Securities maintained Motif Bio PLC (LON:MTFB) on Wednesday, November 25 with “Speculative Buy” rating. As per Tuesday, March 15, the company rating was maintained by Beaufort Securities.
More recent Motif Bio PLC (LON:MTFB) news were published by: Streetinsider.com which released: “Motif Bio plc (MTFB) IPO Opens Lower” on November 18, 2016. Also Uk.Finance.Yahoo.com published the news titled: “Motif Bio Plc (MTFB.L)” on April 02, 2015. Reuters.com‘s news article titled: “BRIEF-Motif Bio Plc’s ADS opens at $5.52 in US market debut” with publication date: November 18, 2016 was also an interesting one.
Motif Bio plc is a clinical-stage biopharmaceutical company. The company has a market cap of 40.19 million GBP. The Firm is engaged in development of antibiotics, which are designed for treatment of infections caused by multi-drug resistant bacteria. It currently has negative earnings. It operates in the development and commercialization of pharmaceutical formulations segment.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.